Zhang, Qiang
Dong, Shiyang
Shi, Chonglong
Jin, Wenjie
Article History
Received: 2 November 2024
Accepted: 24 February 2025
First Online: 1 March 2025
Declarations
:
: This prospective randomized controlled trial was approved by the Ethics Committee of the First Affiliated Hospital of Nanjing Medical University on May 12, 2023 (approval number: 2023-SR-745) and retrospectively registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2400088996). All patients signed a written informed consent.
: Not applicable.
: The authors declare no competing interests.